Provided by Tiger Fintech (Singapore) Pte. Ltd.

T2 Biosystems

0.1627
+0.01268.39%
Volume:71.86K
Turnover:11.80K
Market Cap:4.56M
PE:-0.04
High:0.1700
Open:0.1550
Low:0.1550
Close:0.1501
Loading ...

T2 Biosystems Reduces Workforce Amid Nasdaq Delisting Notice

TIPRANKS
·
15 Feb

T2 Biosystems Gets Nasdaq Delisting Notice; Shares Down

MT Newswires Live
·
12 Feb

BRIEF-T2 Biosystems Enters Amendment No. 12 To Term Loan Agreement

Reuters
·
17 Jan

T2 Biosystems Inc - Enters Amendment No. 12 to Term Loan Agreement

THOMSON REUTERS
·
17 Jan

T2 Biosystems Inc - Maturity Date Extended to March 31, 2026

THOMSON REUTERS
·
17 Jan

T2 Biosystems Inc - Expects T2resistance Panel FDA Submission in Q1 2025

THOMSON REUTERS
·
07 Jan

T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

THOMSON REUTERS
·
07 Jan

T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
07 Jan

T2 Biosystems Enhances Governance and Leadership Stability

TIPRANKS
·
04 Jan

T2 Biosystems Announces Sale of Four T2dx Instruments to Existing European Distributor

THOMSON REUTERS
·
18 Dec 2024

T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor

GlobeNewswire
·
18 Dec 2024

T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally

GlobeNewswire
·
17 Dec 2024

T2 Biosystems Extends Capital Equipment Supplier Deal With Vizient; Shares Rise

MT Newswires Live
·
17 Dec 2024

T2 Biosystems extends multi-year supplier agreement with Vizient

TIPRANKS
·
16 Dec 2024

T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement With Vizient, Inc.

THOMSON REUTERS
·
16 Dec 2024

T2 Biosystems Inc - Extends Agreement With Vizient Through March 2026

THOMSON REUTERS
·
16 Dec 2024

T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.

GlobeNewswire
·
16 Dec 2024

T2 Biosystems announces plans to license technology to expand its leadership

TIPRANKS
·
09 Dec 2024

T2 Biosystems Announces Plans to License Its Proprietary Technology to Expand Its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens

THOMSON REUTERS
·
09 Dec 2024

T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens

GlobeNewswire
·
09 Dec 2024